Luveris FDA Approval History
FDA Approved: Yes (Discontinued) (First approved October 8, 2004)
Brand name: Luveris
Generic name: lutropin alfa
Dosage form: for Injection
Company: Serono, Inc.
Treatment for: Female Infertility
Marketing Status: Discontinued
Luveris (lutropin alfa) is a recombinant human form of luteinizing hormone indicated for use in combination with follitropin alfa for the stimulation of follicular development in infertile women.
Development timeline for Luveris
|Oct 8, 2004||Approval Luveris Serono, Inc. - Treatment for Infertility|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.